Depression trials recruiting in New York

All Depression trials nationally

Cities in New York

Recruiting trials in New York

• A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
  NCT05507138 · Phase: Phase 2 · Ages: 50 Years to 79 Years · Sex: All (male and female) · New York: New York
• A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
  NCT05920252 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 18 Years · Sex: All (male and female) · New York: New York
• A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
  NCT06508450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 34 Years · Sex: All (male and female) · New York: The Bronx
• A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients
  NCT07390331 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT07115329 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · New York: Cedarhurst, New York
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
  NCT07592689 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: New York
• A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
  NCT05081596 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · New York: White Plains
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
  NCT03887715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Amherst, Buffalo, Lewiston, New York
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
  NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Brooklyn, Cedarhurst, Staten Island
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
  NCT06775379 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Brooklyn, Staten Island
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Mount Kisco, New York
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
  NCT05574127 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · New York: New York
• A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
  NCT07716098 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
  NCT07573176 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Brooklyn, Mount Kisco, New York
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
  NCT06793397 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: New York
• A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer
  NCT07218250 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: Commack, Harrison, New York, Uniondale
• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
  NCT06696755 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  NCT04777357 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New York: Buffalo
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
  NCT07276997 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
  NCT06524830 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
  NCT07621237 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
  NCT07610473 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
  NCT07300969 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
  NCT07065240 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, Cedarhurst, New York, Staten Island
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
  NCT06223880 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, Mount Kisco, New York, Staten Island
• A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT07196501 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Glen Oaks
• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
  NCT07284667 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn
• ALTO-207 in Adults With Treatment-resistant Depression (TRD)
  NCT07553637 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Amherst, Cedarhurst, Lewiston, Syracuse
• An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
  NCT05466851 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Assessment of Music Experiences in Navigating Depression Part 2
  NCT07218055 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 15 Years · Sex: All (male and female) · New York: New York
• Aβ Dynamics in LLMD
  NCT05004987 · Phase: Phase 4 · Ages: 60 Years and older · Sex: All (male and female) · New York: New York, Orangeburg
• Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
  NCT07812870 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 17 Years · Sex: All (male and female) · New York: Stony Brook
• Biomarker-guided rTMS for Treatment Resistant Depression
  NCT04041479 · Phase: Phase 3 · Ages: 22 Years to 65 Years · Sex: All (male and female) · New York: New York
• Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
  NCT05925322 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · New York: New York
• Brief Interventions for Coping with Distress
  NCT05779761 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
  NCT07484217 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, New York, Staten Island, The Bronx
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · New York: Amherst, Brooklyn, New York, Syracuse
• DBS for Depression
  NCT06096207 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Queens
• DBS for TRD With the Medtronic Percept PC
  NCT05773755 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 70 Years · Sex: All (male and female) · New York: New York
• DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
  NCT07225088 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 100 Years · Sex: All (male and female) · New York: Commack, Harrison, New York, Rockville Centre
• Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
  NCT06835855 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Months and older · Sex: All (male and female) · New York: Binghamton
• Digital CBT for Insomnia and Depression
  NCT05456607 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• E-Mindfulness Approaches for Living After Breast Cancer
  NCT06748222 · Phase: Phase 3 · Ages: 18 Years to 50 Years · Sex: All (male and female) · New York: Astoria, Glens Falls, Middletown, New York
• Effects of "Alliance180 Program" on Well-Being
  NCT06451523 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Saratoga Springs
• Engage & Connect: A Psychotherapy for Postpartum Depression
  NCT05585164 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female · New York: New York
• Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
  NCT06830044 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York, Staten Island
• Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals
  NCT05897619 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: New York
• Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
  NCT07111390 · Phase: Not applicable (e.g. observational or device study) · Ages: 24 Years to 65 Years · Sex: All (male and female) · New York: New York
• Harlem Strong Mental Health Coalition
  NCT05833555 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)
  NCT06455527 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
  NCT06901687 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Implementation of a Clinical Decision Support Tool for Postpartum Depression
  NCT06818734 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: Brooklyn, New York
• Improving the Mental Health of Home Health Aides
  NCT06071221 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
  NCT05239780 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: New York
• Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
  NCT06559826 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · New York: New York
• Lay-Delivered Behavioral Activation in Senior Centers
  NCT04621877 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · New York: Brooklyn, New York
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Cedarhurst, Mount Kisco, New York, The Bronx
• Maintenance rTMS for Depression (Maitr-De)
  NCT06938841 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: New York
• Mind-Body Skills Group for Graduate Students
  NCT05447689 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: White Plains
• Mindfulness-Based fMRI Neurofeedback for Depression
  NCT05617495 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 18 Years · Sex: All (male and female) · New York: New York
• Mobile CBT for Middle Aged and Older Adults
  NCT05754151 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• Mobile Cognitive Behavioral Therapy for Stroke
  NCT06689878 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 79 Years · Sex: All (male and female) · New York: New York
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
  NCT06372964 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New York: New York
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
  NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06911112 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, The Bronx
• NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06963021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Cedarhurst, New York
• Nebulized Ketamine for the Treatment of Major Depressive Disorder
  NCT06752759 · Phase: Phase 3 · Ages: 18 Years to 88 Years · Sex: All (male and female) · New York: Brooklyn
• Neural Circuit Effects of Ketamine in Depression
  NCT06213324 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Neural and Psychiatric Consequences of Cannabis Use in Adolescents
  NCT06941298 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 20 Years · Sex: All (male and female) · New York: Orangeburg
• Neutralizing Interleukin (IL)-6
  NCT07493317 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York
• Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
  NCT06854224 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: The Bronx
• PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
  NCT07095205 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Stony Brook
• Pattern Separation in Major Depressive Disorder
  NCT07139834 · Phase: Phase 1 · Ages: 18 Years to 50 Years · Sex: All (male and female) · New York: New York
• Personalized Mobile Cognitive Behavioral Therapy Application
  NCT05699525 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 25 Years · Sex: All (male and female) · New York: New York
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
  NCT06559306 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Brooklyn, Buffalo, Mount Kisco, New York
• Prevention of Psychological Health Problems Via Integrated Operational Support
  NCT06981598 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
  NCT06592833 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female) · New York: New York
• Psilocybin as a Novel Therapy for Residual Anhedonia
  NCT07607938 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Psilocybin to Treat Depression in Spinal Cord Injury
  NCT07251491 · Phase: Phase 1, Phase 2 · Ages: 22 Years and older · Sex: All (male and female) · New York: The Bronx
• Psilocybin-Assisted Therapy for Intergenerational Trauma
  NCT06899165 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
  NCT06123325 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: The Bronx
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: Buffalo, New York
• ROSE in Sunset Park
  NCT04940585 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: Female · New York: New York
• Readiness and Progress in Emotion Regulation Therapy
  NCT07478393 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• SAINT in Postpartum Depression (PPD)
  NCT07210255 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: Female · New York: New York
• SilverCloud as a School-Based Intervention for Vulnerable Youth
  NCT06004414 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 22 Years · Sex: All (male and female) · New York: Brooklyn, Glen Oaks
• Sleep More, Stress Less: 90-Day Trial of Neuralli Mood
  NCT07717385 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
  NCT05757791 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
  NCT06129903 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Commack, Harrison, New York, Uniondale
• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
  NCT06633016 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, New York, Staten Island
• Study of ALTO-300 in MDD
  NCT05922878 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: Rochester, Staten Island
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
  NCT05850689 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: Brooklyn, New York
• Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06786624 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Mount Kisco
• TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
  NCT07048574 · Phase: Not specified · Ages: 18 Months to 11 Years · Sex: All (male and female) · New York: Buffalo
• Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
  NCT06039930 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · New York: New York
• Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
  NCT05734313 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · New York: The Bronx
• Telephone-Based Support Programs for People With Epilepsy
  NCT05082181 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: New York
• Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University
  NCT07188467 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn
• The Role of mGluR5 in CBT-I
  NCT07076342 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: Stony Brook